Cancer diagnostics

March 16, 2020

A good indicator of dysregulation in live cells is a change in their RNA expression. MicroRNA (miRNA), a special type of RNA, is considered a biomarker for carcinogenic cells. A team of scientists from China has found a way to amplify miRNA in live tumor cells for bioimaging. As they report in the journal Angewandte Chemie, their assay is based on a robust cellular autocatalytic biocircuit triggered by synthetic DNA and nanoparticles.

Diagnosing cancer before a tumor becomes visible has been one of the long-standing goals in medicine. One of the biomarkers for carcinogenicity in a cell is its RNA expression pattern or, more precisely, the change in RNA expression, which causes metabolic degeneration. There are many types of RNA, among which a short noncoding RNA called miRNA promotes or impedes the translation of nucleus-encoded genetic information into protein. Accordingly, the detection of a changed miRNA expression profile is thought to be a reliable indication of the degeneration of a cell.

However, the detection of a particular miRNA is difficult because it is present in the cell only in tiny amounts and must by amplified and connected to a signaling entity, such as a fluorescence dye, for visualization. A team of scientists at Wuhan University, China, led by Fuan Wang, have discovered a suitable amplification-detection mechanism for miRNA, which relies on an autocatalytic biocircuit activated by synthetic DNA, leading to a strong fluorescence signal that flags tumor cells.

RNA is usually synthesized in the nucleus of the cell and transported to the cytoplasm where it conveys genetic information. However, when synthetic DNA is present in the cytoplasm, RNA can bind to a matching nucleotide sequence of the DNA strand; a fact that is exploited in, for example, antiretroviral treatment to silence viral RNA expression. Wang and his coworkers did the opposite. By matching synthetic DNA strands with miRNA, they triggered an autocatalytic amplification circuit--called autocatalytic DNAzyme biocircuit--to form DNA-miRNA assemblies. These assemblies grew further to form DNAzyme nanowires that carry the fluorescence dyes.

After administering the DNAzyme detection kit, the authors observed bright fluorescence in a mouse model at the location where a tumor was developing.

To make the DNAzyme enter the tumor cells, the authors used nanoparticles--tiny parcels that can deliver drugs and other molecular freight to the cells--made of manganese dioxide with a honeycomb-like structure. According to the authors, this composition and architecture has the advantage that the nanoparticle can be readily activated by glutathione, which is a chemical found in abundance in tumor cells. Another advantage is that the released manganese ions would sustain the autocatalytic DNAzyme biocircuit, the authors write.

The scientists emphasize that their self-enhanced bioimaging system could be developed as a powerful tool to visualize tumor cells with biomarkers. This is especially promising as many different miRNAs can be selectively targeted to investigate different cancers or other cell dysfunction.
-end-
About the Author

Dr. Fuan Wang is a Professor of chemistry at the Key Laboratory of Analytical Chemistry for Biology and Medicine at Wuhan University, China. His group is devoted to the investigation of synthetic DNA nanostructures for diagnostic, imaging, and medicinal applications.

https://www.chemistry.nus.edu.sg/people/academic_staff/yaosq.htm

Wiley

Related Tumor Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

How to prevent the spread of tumor cells via the lymph vessels
Scientists from the German Cancer Research Center and the Mannheim Medical Faculty of the University of Heidelberg identified a new way to block the dangerous spread of tumor cells via lymphatic vessels.

The CNIO reprograms CRISPR system in mice to eliminate tumor cells without affecting healthy cells
CNIO researchers destroyed Ewing's sarcoma and chronic myeloid leukaemia tumor cells by using CRISPR to cut out the fusion genes that cause them.

Feeding off fusion or the immortalization of tumor cells
Despite all recent progress, cancer remains one of the deadliest human diseases.

How do tumor cells divide in the crowd?
Scientists led by Dr. Elisabeth Fischer-Friedrich, group leader at the Excellence Cluster Physics of Life (PoL) and the Biotechnology Center TU Dresden (BIOTEC) studied how cancer cells are able to divide in a crowded tumor tissue and connected it to the hallmark of cancer progression and metastasis, the epithelial-mesenchymal transition (EMT).

How tumor cells evade the immune defense
Scientists are increasingly trying to use the body's own immune system to fight cancer.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

New pathway to attack tumor cells identified
A study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumor causing cell destruction by autophagy.

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.

Blocking sugar structures on viruses and tumor cells
During a viral infection, viruses enter the body and multiply in its cells.

Read More: Tumor Cells News and Tumor Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.